Florida Medicaid plan
Pfizer has been approached by a "number of other states, and in fact, countries" to strike a Medicaid program deal similar to that in Florida, CEO Hank McKinnell tells analysts July 17. "We've had to make it very clear that this is a pilot and before we're really ready to replicate it we need to demonstrate that this program really works." Pfizer is offering Florida free drugs in exchange for continued unrestricted access to the state's Medicaid formulary (1"The Pink Sheet" May 21, p. 4). "I think for our industry, this is absolutely the right way to be going. But on the other hand, we haven't demonstrated that we can actually do this yet"
Learn what's happening at the US FDA. On the go.
More from Archive
- • By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
- • By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
More from Pink Sheet
- • By
It is unclear in a revised staff manual guide whether Commissioner's National Priority Voucher program approval “recommendations” from the drug and biologic center directors will be advisory or decisional, experts told the Pink Sheet.
- • By
Revised recommendation is based on most recent data on circulating strains in US, where KP.3 is now dominant. Novavax sticks with plans targeting the JN.1 ‘parent strain.’
- • By
Pink Sheet reporter and editors discuss the US FDA’s changes to the COVID-19 vaccine indication and its revocation of the vaccine emergency use authorizations, as well as new vaccine coverage and reimbursement questions.
